TKCANINE CANCER PANEL
Patient Values Chronologically
TK
U/L
CRP
CRP
mg/L
TK
64
45
16
30
25
4
3
4
3
2
1
1-Apr-13
ABN
CRP
1-Mar-13
1-Feb-13
1-Jan-13
1-Dec-12
2
1-Nov-12
1-Oct-12
1-Sep-12
1-Aug-12
1-Jul-12
1
1-Jun-12
1-May-12
1
1-Apr-12
1-Mar-12
1-Jan-12
2
1-Feb-12
2
1
Hpt
Hpt
mg/dL
TK
33
400
16
10
ABN
TK
4
6
6
5
6
200
182
78
61
46
33
37 ABN
1-Mar-13
1-Feb-13
1-Jan-13
1-Dec-12
1-Nov-12
1-Oct-12
1-Sep-12
1-Aug-12
1-Jul-12
1-Jun-12
1-May-12
1-Apr-12
1-Mar-12
Hpt
1-Feb-12
Treatment: 25 week MadisonWisconsin protocol
Monitoring: Upon initiation, both TK
& CRP dropped within normal range,
indicating a positive response to
treatment. Periodic rechecks confirmed
status of complete remission during
treatment course. Following induction
therapy, test monitoring took place
every 3 months in unison with recheck
exams. The chart records slight
variatons in TK level, but no steady
trend in an upward direction, which
often occurs just prior to the patient
coming out of remission.
Feline Case Study
History: 13 year old DSH diagnosed
with multicentric lymphoma
64
27
History: 11 year old boxer diagnosed
with multicentric lymphoma
TK FELINE CANCER PANEL
Patient Values Chronologically
TK
U/L
15
1-May-13
ABN
TK
Canine Case Study
Treatment: 25 week MadisonWisconsin protocol
Monitoring: Upon initiation, Hpt
(systemic inflammation) dropped
notably, indicating a positive response
to treatment. Short-term rise in TK
(cell proliferation) associated with
mass destruction of tumor cells is seen
followed by quick decline in TK.
Periodic rechecks confirmed status of
complete remission during treatment
course. Post-treatment, the chart
records slight variatons in TK level, but
no steady trend in an upward direction,
which often occurs just prior to the
patient coming out of remission.
9